Mesenchymal stem cells maintain their defining stem cell characteristics after treatment with cisplatin

Explore this paper's citation graph

Summary

It is demonstrated that human bone marrow-derived MSCs are relatively resistant to cisplatin treatment and show resistance levels comparable to these of differentiated fibroblasts.

Type
article
Published
2016-01-25
Cited by
36
References
63
Access
Open access

Keywords

Cisplatin, Mesenchymal stem cell, Stem cell, Cell biology, Cancer research

References

Cited by

Related papers